Pharma Real-Word Data & Evidence Market Report, First Edition: 2025-2030

Download a sample of the report here.

This first edition report provides a comprehensive overview of the global Real-World Data & Evidence (RWD/E) market from 2025 to 2030. The market is defined as revenue generated from the generation, aggregation, and analysis of real-world data by biopharma, CROs, and other stakeholders. The ecosystem encompasses a diverse set of players spanning data generators, aggregators, and enablers, with vendor selection driven by data type, quality, access model, and analytic sophistication.

‍

The RWD/E market is positioned for rapid growth as the use of real-world insights becomes increasingly embedded across the product lifecycle. Expanding regulatory acceptance of RWE, growing investment in multimodal datasets, and the integration of AI-enabled analytics are driving adoption. However, the market continues to face headwinds, including interoperability challenges, fragmented data quality, and evolving data privacy regulations. Balancing these dynamics, we estimate that the global RWD/E market will grow from ~$2.5B in 2025 to ~$4.7B by 2030, reflecting a CAGR of ~14%.

‍

This report is informed by 35 in-depth primary stakeholder interviews and extensive secondary research. The market model employs a bottoms-up approach based on average RWD spend of key customer groups (e.g., large and small biopharma, and CROs). The market is segmented by product type, use case, therapeutic area, and data type. 

For each segment, the report analyzes vendor positioning, partnerships, and market evolution in 2025, 2028, and 2030. We also examine major market drivers and barriers, ecosystem trends, and implications for data strategy, partnerships, and investment.

‍

Segmentations Covered in Market Analysis:

Data Type

• Electronic Health Records (EHR / EMR)
  
  
• Claims
  
  
• Omics / Clinical-Omic
  
  
• Imaging
  
  
• Other Real-World Datasets
  
  

Customer Type

• Large Pharma
  
  
• Small & Mid Pharma
  
  
• CROs
  
  

Use Case

• Discovery Research
  
  
• Clinical Development
  
  
• Commercial Development
  
  

Therapeutic Area

• Oncology
  
  
• Cardio-Metabolic
  
  
• Immunology
  
  
• Neurology
  
  
• Rare Disease
  
  
• Other
  
  

Geography

• United States
  
  
• Europe
  
  
• Rest of World

‍